Free Trial

Biogen (BIIB) SEC Filings & 10K Form

Biogen logo
$140.33 -2.10 (-1.47%)
Closing price 03/27/2025 04:00 PM Eastern
Extended Trading
$141.50 +1.17 (+0.83%)
As of 03/27/2025 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Biogen SEC Filings

DateFilerForm TypeView
03/07/2025
3:18 PM
Biogen (Subject)
SHERWIN STEPHEN A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2025
4:40 PM
Biogen (Issuer)
Izzar Rachid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
4:42 PM
ALEXANDER SUSAN H (Reporting)
Biogen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
4:43 PM
Biogen (Issuer)
Gregory Ginger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
4:44 PM
Biogen (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
4:46 PM
Biogen (Issuer)
MCDONNELL MICHAEL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
4:47 PM
Biogen (Issuer)
Murphy Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
4:48 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
4:28 PM
Biogen (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2025
6:06 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2025
8:52 PM
Biogen (Issuer)
Izzar Rachid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
5:55 PM
Biogen (Issuer)
Viehbacher Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
5:59 PM
Biogen (Issuer)
MCDONNELL MICHAEL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
5:42 PM
ALEXANDER SUSAN H (Reporting)
Biogen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
5:44 PM
Biogen (Issuer)
Gregory Ginger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
5:45 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
5:47 PM
Biogen (Issuer)
Murphy Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
5:48 PM
Biogen (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
5:49 PM
Biogen (Issuer)
Izzar Rachid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
5:51 PM
Biogen (Issuer)
Keeney Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
5:52 PM
Biogen (Issuer)
Grogan Jane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
5:02 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
7:00 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
4:34 PM
Biogen (Filed by)
Sage Therapeutics, Inc. (Subject)
Form SCHEDULE 13D
01/07/2025
3:14 PM
Biogen (Issuer)
Pangalos Menelas N (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/09/2024
3:56 PM
Biogen (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
3:57 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
9:33 AM
Biogen (Subject)
Singhal Priya (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2024
3:23 PM
ALEXANDER SUSAN H (Reporting)
Biogen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
10:20 AM
Biogen (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/30/2024
3:45 PM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
3:31 PM
Biogen (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2024
5:55 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
11:11 AM
Biogen (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
10/07/2024
6:08 PM
Biogen (Issuer)
Minor Lloyd (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
6:31 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
5:00 AM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
12:00 PM
Biogen (Subject)
Singhal Priya (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
5:40 PM
Biogen (Filed by)
SANGAMO THERAPEUTICS, INC (Subject)
Form SC 13G/A
08/01/2024
5:55 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
4:01 PM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Musk’s real agenda in D.C. (Ad)

In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…

06/25/2024
4:06 PM
Biogen (Issuer)
DORSA CAROLINE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:13 PM
Biogen (Issuer)
Freire Maria C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:14 PM
Biogen (Issuer)
HAWKINS WILLIAM A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:15 PM
Biogen (Issuer)
Patolawala Monish D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:16 PM
Biogen (Issuer)
LANGER SUSAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:18 PM
Biogen (Issuer)
Rowinsky Eric K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:19 PM
Biogen (Issuer)
Mantas Jesus B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:20 PM
Biogen (Issuer)
SHERWIN STEPHEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
4:08 PM
Biogen (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/03/2024
7:00 PM
Biogen (Issuer)
Keeney Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2024
4:15 PM
Biogen (Filer)
Form ARS
04/24/2024
3:15 PM
Biogen (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2024
6:02 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2024
4:01 PM
Biogen (Filer)
Form PRE 14A
04/03/2024
7:24 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:11 PM
Biogen (Issuer)
Murphy Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
9:08 AM
Biogen (Subject)
Singhal Priya (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:BIIB) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners